유세포 분석 시장 : 제품 및 서비스, 기술, 응용 분야, 최종 사용자별 - 세계 예측(2025-2030년)

The Flow Cytometry Market was valued at USD 5.51 billion in 2023, expected to reach USD 6.01 billion in 2024, and is projected to grow at a CAGR of 9.36%, to USD 10.32 billion by 2030.

Flow cytometry is a critical technology used extensively in research and clinical laboratories for analyzing the physical and chemical characteristics of cells or particles. Its necessity stems from its applications in cell counting, biomarker detection, and protein engineering, making it indispensable in diagnostics, pharmaceuticals, and academic research. End-use sectors include hospitals, clinical testing labs, and research institutions, where flow cytometry is used for disease diagnosis, drug development, and hematology studies. Growth in the flow cytometry market is driven by advancements in cell-based assays and the rising prevalence of chronic diseases, which necessitate robust diagnostic technologies. The increasing demand for personalized medicine and the development of new technologies, such as spectral flow cytometry, offer potential growth opportunities. However, challenges like high instrument costs and the complexity of data analysis can hinder market growth. Companies that focus on simplifying the user interface and providing automation solutions can effectively tap into emerging markets. Innovation areas include microfluidics, which enhance sample processing speed, and the integration of artificial intelligence, which can significantly improve data interpretation and accuracy. Investment in these areas can yield substantial competitive advantages. To overcome limitations, market players should invest in training programs to address the skill gap associated with operating sophisticated instruments and interpreting large datasets. Strategic partnerships with biotechnology firms can also help broaden application scopes, fostering enhanced R&D capabilities. The flow cytometry market is highly competitive, with ongoing research and development efforts by key players aiming to introduce cost-effective and user-friendly solutions. By adopting a customer-centric approach and focusing on emerging trends, stakeholders can effectively navigate challenges and capitalize on new growth avenues. Enhanced regulatory frameworks and strategic collaborations will further bolster market expansion and innovation. Overall, flow cytometry presents a dynamic landscape ripe for advancements that promise to enhance its utility across various technological and clinical aspects.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Flow Cytometry Market

The Flow Cytometry Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases such as cancer and HIV
  • Surging research activities in biomedical and cancer research
  • Rising prevalence of chronic and infectious diseases
• Market Restraints
  • High cost of the product and lack of trained expertise
• Market Opportunities
  • Emerging presence of tandem flow cytometry technologies and inclusion of AI in flow cytometry
  • Growing preference for flow cytometry in drug discovery and development
• Market Challenges
  • Data management and interpretation complexity

Porter's Five Forces: A Strategic Tool for Navigating the Flow Cytometry Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Flow Cytometry Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Flow Cytometry Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Flow Cytometry Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Flow Cytometry Market

A detailed market share analysis in the Flow Cytometry Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Flow Cytometry Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Flow Cytometry Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Flow Cytometry Market

A strategic analysis of the Flow Cytometry Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Flow Cytometry Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Apogee Flow Systems, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cytek Biosciences, Inc., Enzo Life Sciences, Inc., General Electric Company, GenScript Biotech Corporation, Luminex Corporation, Miltenyi Biotec, Nanocellect Biomedical, Inc., Novozymes A/S, On-Chip Biotechnologies Co., Ltd., Sartorius AG, Sony Biotechnology Inc., Standard BioTools, Stratedigm Inc., Thermo Fisher Scientific, Inc., and Union Biometrica, Inc..

Market Segmentation & Coverage

This research report categorizes the Flow Cytometry Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Accessories, Flow Cytometry Instruments, Reagents & Consumables, Services, and Software. The Flow Cytometry Instruments is further studied across Cell Analyzers and Cell Sorters. The Cell Analyzers is further studied across High-Range Cell Analyzers, Low-Range Cell Analyzers, and Mid-Range Cell Analyzers. The Cell Sorters is further studied across High-Range Cell Sorters, Low-Range Cell Sorters, and Mid-Range Cell Sorters. The Reagents & Consumables is further studied across Antibodies and Assays & Kits.
• Based on Technology, market is studied across Bead-Based Flow Cytometry and Cell-Based Flow Cytometry.
• Based on Application, market is studied across Clinical Applications, Industrial Applications, and Research Applications. The Clinical Applications is further studied across Cancer, Hematology, Immunodeficiency Diseases, and Organ Transplantation.
• Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases such as cancer and HIV
    • 5.1.1.2. Surging research activities in biomedical and cancer research
    • 5.1.1.3. Rising prevalence of chronic and infectious diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the product and lack of trained expertise
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging presence of tandem flow cytometry technologies and inclusion of AI in flow cytometry
    • 5.1.3.2. Growing preference for flow cytometry in drug discovery and development
  • 5.1.4. Challenges
    • 5.1.4.1. Data management and interpretation complexity
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product & Service: Proliferating adoption of the flow cytometry instruments owing to their performance and cost effectivenes
  • 5.2.2. End-User: Evolving utilization of the flow cytometry tools across the pharmaceutical and biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Flow Cytometry Market, by Product & Service

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Flow Cytometry Instruments
  • 6.3.1. Cell Analyzers
    • 6.3.1.1. High-Range Cell Analyzers
    • 6.3.1.2. Low-Range Cell Analyzers
    • 6.3.1.3. Mid-Range Cell Analyzers
  • 6.3.2. Cell Sorters
    • 6.3.2.1. High-Range Cell Sorters
    • 6.3.2.2. Low-Range Cell Sorters
    • 6.3.2.3. Mid-Range Cell Sorters
• 6.4. Reagents & Consumables
  • 6.4.1. Antibodies
  • 6.4.2. Assays & Kits
• 6.5. Services
• 6.6. Software

7. Flow Cytometry Market, by Technology

• 7.1. Introduction
• 7.2. Bead-Based Flow Cytometry
• 7.3. Cell-Based Flow Cytometry

8. Flow Cytometry Market, by Application

• 8.1. Introduction
• 8.2. Clinical Applications
  • 8.2.1. Cancer
  • 8.2.2. Hematology
  • 8.2.3. Immunodeficiency Diseases
  • 8.2.4. Organ Transplantation
• 8.3. Industrial Applications
• 8.4. Research Applications

9. Flow Cytometry Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospitals & Clinical Testing Laboratories
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Flow Cytometry Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Flow Cytometry Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Flow Cytometry Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Agilent's NovoCyte Opteon Spectral Flow Cytometer Enhances Precision in Medical Research and Drug Development
  • 13.3.2. New CytoFLEX nano Flow Cytometer from Beckman Coulter Life Sciences, Enhanced Detection and Characterization of Nanoparticles as Small as 40 nm
  • 13.3.3. Sysmex Corporation Introduces Fully Automated Clinical Flow Cytometry System to Japan
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Apogee Flow Systems
• 3. Beckman Coulter, Inc.
• 4. Becton, Dickinson and Company
• 5. Bio-Rad Laboratories, Inc.
• 6. bioMerieux SA
• 7. Cytek Biosciences, Inc.
• 8. Enzo Life Sciences, Inc.
• 9. General Electric Company
• 10. GenScript Biotech Corporation
• 11. Luminex Corporation
• 12. Miltenyi Biotec
• 13. Nanocellect Biomedical, Inc.
• 14. Novozymes A/S
• 15. On-Chip Biotechnologies Co., Ltd.
• 16. Sartorius AG
• 17. Sony Biotechnology Inc.
• 18. Standard BioTools
• 19. Stratedigm Inc.
• 20. Thermo Fisher Scientific, Inc.
• 21. Union Biometrica, Inc.